Seeking individuals ages 16-40 with Schizophrenia, Schizophreniform or Bipolar Disorder to complete a 16-week medication study
The purpose of the Enlighten Early study is to measure the effects of a new medication called ALKS 3831 on body weight in young adults with Schizophrenia, Schizophreniform or Bipolar Disorder.
Improving health outcomes and supporting weight management in adults ages 18-65 who are currently taking antipsychotic medication
We're testing the effectiveness of an interactive obesity treatment approach (iOTA) in adults with severe mental illness (SMI). This treatment combines in-person health coaching visits with daily text messages to help keep you motivated and on track with your health and weight management goals.
Seeking older adults (ages 60-85) with depression to complete a 6-week study
This study will examine whether an intervention using magnets called intermittent Theta Burst Stimulation (iTBS) alleviates depression and improves people’s ability to plan, make decisions and take action.
MEDEX is a research study involving classes, health screenings and memory assessments to improve memory and concentration for adults ages 65+
MEDEX is a research study to examine the benefits for older adults of Mindfulness-Based Stress Reduction (MBSR), health education, and exercise to improve memory, attention, and concentration. Enrollment is now closed.
Improving treatment for adults 60+ who are currently depressed and taking antidepressant medication
Optimum is a research study to find out which medications work best and are safest for individuals who are 60+.